SCHEMBL17786382

SCHEMBL17786382

Nc1ccc2sc(-c3ccccc3)cc(=O)c2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.60
APP P05067 1/20 0.50
ALDH1A1 P00352 4/20 0.49
HPGD P15428 4/20 0.49
MAPT P10636 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MAPK1 P28482 2/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
TP53 P04637 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP1A1 P04798 2/20 0.48
CYP1B1 Q16678 2/20 0.48
MAPK3 P27361 1/20 0.44
MAP2K1 Q02750 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17786507 0.84 STS (0.45) STSAPPALDH1A1HPGDMAPT
SCHEMBL1374464 0.81 ALDH1A1 (0.69) STSAPPALDH1A1HPGDMAPT
SCHEMBL17786521 0.81 ALDH1A1 (0.68) STSAPPALDH1A1HPGDMAPT
SCHEMBL2305474 0.81 STS (0.57) STSALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL10714283 0.75 STS (0.55) STSAPPALDH1A1HPGDMAPT
SCHEMBL13299937 0.74 ESR1 (0.50) STSAPPALDH1A1HPGDMAPT
SCHEMBL17786496 0.73 NQO2 (0.57) STSALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL11477316 0.73 STS (0.49) STSALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL15089105 0.73 ALDH1A1 (0.52) APPALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL11476689 0.73 ALDH1A1 (0.59) STSALDH1A1HPGDMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016083490-A1 COMPOUNDS FOR THE TREATMENT OF AMYLOID-ASSOCIATED DISEASES REMYND NV (BE) 2016-06-02 WO disclosed